![Benjamin Winograd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Winograd
Geen lopende functies
Profiel
Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.
Eerdere bekende functies van Benjamin Winograd
| Bedrijven | Functie | Einde |
|---|---|---|
| LAVA THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 06-02-2023 |
| CELGENE | Corporate Officer/Principal | 01-01-2020 |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Corporate Officer/Principal | 01-01-2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-1999 |
Opleiding van Benjamin Winograd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Commercial Services |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
